When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. Hinge Health just cleared that benchmark with an upgrade from 79 to 87.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners typically have an RS Rating north of 80 in the early stages of their moves.
The stock, which is on theIPO Leaders list, is trading within a buy range after moving past a 43.80 entry in a ipo base. Once a stock moves 5% or higher beyond the original entry, it's considered out of a proper buy zone.
The company reported 0% earnings growth last quarter, while sales growth came in at 50%. Keep an eye out for the company's next round of numbers on or around Aug. 5.
Hinge Health holds the No. 6 rank among its peers in the Medical-Products industry group. Insulet, Boston Scientific and ResMed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
